Get access to our best features
Get Started
SubscribeLogin
Get access to our best features
Get Started
Published

Bausch + Lomb eyeing sale amid spinoff concerns (NYSE:BLCO)

Summary by The New York Ledger
JHVEPhoto/iStock Editorial through Getty Images Bausch + Lomb ( NYSE: BLCO) is checking out a sale to deal with issues raised by lending institutions such as Apollo Global Management (APO) over its scheduled separation from its moms and dad, Bausch Health ( NYSE: BHC), The Financial Times reported Saturday. According to individuals acquainted with the matter, the Canadian eyecare company is dealing with advisors from Goldman Sachs to assess …
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Mississauga

Mississauga

Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2025 Snapwise Inc
News
For You
Search
BlindspotLocal